Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial
Hiddo J.L. Heerspink, Naveed Sattar, Imre Pávó, Axel Haupt, Kevin L. Duffin, Zhengyu Yang, Russell J. Wiese, Katherine R Tuttle, David Z.I. Cherney
Topics & Concepts
MedicineInsulin glargineType 2 diabetesPost-hoc analysisRenal functionInternal medicineDiabetes mellitusPopulationMetforminCreatinineAlbuminuriaInsulinEndocrinologyEnvironmental healthChronic Kidney Disease and DiabetesDiabetes Treatment and ManagementBlood Pressure and Hypertension Studies